The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research ...

Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and ...

Biocare Medical, which is backed by Excellere Partners, has named Luis de Luzuriaga as CEO. Previously, he was CEO of Bit Group. Biocare is a developer of immunohistochemistry and molecular reagents ...

SAN FRANCISCO and ROSEMONT, Ill., March 23, 2026 /PRNewswire/ -- Biocare Medical, a global leader in immunohistochemistry (IHC) reagents and diagnostic assay solutions, and Proteintech, a global ...

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be ...

Excellere Partners has made an investment in Pacheco, California-based Biocare Medical, a provider of immunohistochemistry instrumentation, as well as a full range of reagents for IHC and molecular ...

Agilent completes acquisition of l clinical pathology leader, Biocare Medical: Santa Clara, California Friday, June 26, 2026, 16:00 Hrs [IST] Agilent Technologies Inc., a global l ...

This article first appeared on GuruFocus. Agilent Technologies (NYSE:A) has agreed to acquire privately held Biocare Medical in an all-cash deal valued at $950 million, a move that could strengthen ...

Agilent Technologies said Monday it agreed to acquire Biocare Medical for $950 million in cash to expand its pathology portfolio. Biocare’s antibody, reagent and instrument business complements ...